Use of tumor growth rate (TGR) to provide useful clinical information in phase I trials and reveal clear drug-specific profiles.
Charles Ferte
No relevant relationships to disclose
Marianna Fernandez
No relevant relationships to disclose
Antoine Hollebecque
No relevant relationships to disclose
Serge Koscielny
No relevant relationships to disclose
Antonin Levy
No relevant relationships to disclose
Rastislav Bahleda
No relevant relationships to disclose
Christophe Massard
No relevant relationships to disclose
Jean-Charles Soria
No relevant relationships to disclose